Embracing the New Era of Immunotherapy in Gastric Cancer Treatment

Advanced gastric cancer still presents a grim outlook, typically yielding a median survival rate of approximately 12 to 15 months. Recently, immune checkpoint inhibitors have emerged as a promising standard treatment for various malignancies, including advanced gastric cancer. They have shown signif...

Full description

Bibliographic Details
Published in:South African Gastroenterology Review
Main Author: Sultan A.H.K.; Chakravarthi S.; Kabir M.S.; Shirin L.; Hardev Singh H.S.; Mazumder M.M.; Farzana Y.; Ying T.S.; Raman K.S.; Chia T.Y.; Noureen A.; Nazmul M.H.M.
Format: Article
Language:English
Published: In House Publications 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182387330&partnerID=40&md5=7d1efd0df491f5c8afbc75fd971cca9c

Similar Items